A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MT / mutation

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MT  (>> Co-occurring Abbreviation)
Long Form:   mutation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 COLD-PCR Method for Early Detection of Antiviral Drug-Resistance Mutations in Treatment-Naive Children with Chronic Hepatitis B. ADF, CHB, COLD, HBV, LMV, NA, RT
2020 Defining Acute Myeloid Leukemia Ontogeny in Older Patients. AHD, AML, pAML, sAML
2020 Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort. mCRC, OS, PFS, WT
2020 MSTN Mutant Promotes Myogenic Differentiation by Increasing Demethylase TET1 Expression via the SMAD2/SMAD3 Pathway. MSTN
2020 SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes. HI, HLA, IST, MDS
2019 Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II-III. 19 del, 21L858R, DFS, EGFR, OS, PBAC, WT
2019 Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer. CRC, EGFR, PIK3CA
2018 ABCB1 genetic polymorphism and pharmacokinetic analysis of low dose erlotinib in frail patients with EGFR mutation (mt)-positive, non-small cell lung cancer: TORG1425. ---
2018 Grade II and III Oligodendroglioma and Astrocytoma. ---
10  2018 Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer. EGFR, NSCLC, OS
11  2018 Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial. DC, DCV, GBM, GSC, OS, PFS, TERT
12  2016 Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others. CRC, MMR
13  2015 Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications. AJCC, IHC, PEAT
14  2015 Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. LOD, MDR-TB, Mtb, NALF, WT
15  2015 Specific in situ hepatitis B viral double mutation (HBVDM) detection in urine with 60 copies ml(-1) analytical sensitivity in a background of 250-fold wild type without DNA isolation and amplification. FRMs, HBVDM, nt, pDNA, PEPS, WT
16  2015 Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. mo, NSCLC
17  2014 CAMKIIgamma, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease. CML, qPCR, TKI
18  2014 Significance of KRAS mutation in patients receiving mFOLFOX6 with or without bevacizumab for metastatic colorectal cancer. mFOLFOX6, OS, PFS, RR, WT
19  2012 Psychiatric symptoms of patients with primary mitochondrial DNA disorders. BDI-SF, GSI, HAQ-DI, HDRS, HN, PMP22, SCL-90-R
20  2010 KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy. CRC, PFS, RPCI, RR, WT
21  2010 p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. CRT, ESCC, IHC, pCR, PCR-SSCP
22  2009 Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. FGFR2, MSCs, PKC, WT
23  2008 Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. cyt b, ROS
24  2008 Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. CP, HBV, HCC, WT
25  2003 Overexpression of nicastrin increases Abeta production. APP, PS, PS, WT
26  2000 Familial growth hormone deficiency with mutated GHRH receptor gene: clinical and hormonal findings in homozygous and heterozygous individuals from Itabaianinha. FGHD, GHRHR, IGFBP-3, SDS, WT
27  1998 Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. ALL, BCP, MESF, PARP, WT